Basics Bristol-Myers Squibb Co. Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products. The company operates in one segment that is Biopharmaceuticals. IPO Date: December 31, 1981 Sector: Healthcare Industry: Pharma Market Cap: $106.69B Activated in VL: True Average Daily Range Avg Daily Range: $0.41 | 0.93% Avg Daily Range (30 D): $0.55 | 1.16% Avg Daily Range (90 D): $0.46 | 0.99% Institutional Daily Volume Avg Daily Volume: 9.42M Avg Daily Volume (30 D): 12.69M Avg Daily Volume (90 D): 11.64M Trade Size Avg Trade Size (Sh.): 179 Avg Trade Size (Sh.) (30 D): 101 Avg Trade Size (Sh.) (90 D): 107 Institutional Trades Total Inst.Trades: 126,792 Avg Inst. Trade: $5.03M Avg Inst. Trade (30 D): $6.43M Avg Inst. Trade (90 D): $6.12M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 22 Market Closing Trades Avg Closing Trade: $56.18M Avg Closing Trade (30 D): $116.66M Avg Closing Trade (90 D): $99.03M Avg Closing Volume: 1.05M     News Dec 14, 2025 @ 1:32 PM Immuno-oncology Clinical Trials Market Projected t... Source: Sns Insider Dec 14, 2025 @ 10:15 AM Want Decades of Passive Income? Buy This Index Fun... Source: David Dierking Dec 9, 2025 @ 5:38 PM BioNTech-Bristol Drug Shows Hope For Breast Cancer... Source: Vandana Singh Dec 7, 2025 @ 2:26 PM Antibody Discovery Market to Reach USD 17.68 Billi... Source: Sns Insider Dec 5, 2025 @ 9:05 PM Do These 3 Healthcare Stocks Need a Checkup? Source: Reuben Gregg Brewer Financials   TTM Q3 2025 Q2 2025 Basic EPS $2.97 $1.08 $.64 Diluted EPS $2.97 $1.08 $.64 Revenue $ 48.03B $ 12.22B $ 12.27B Gross Profit $ 33.38B $ 8.79B $ 8.9B Net Income / Loss $ 6.05B $ 2.2B $ 1.31B Operating Income / Loss $ 8.03B $ 3.11B $ 1.77B Cost of Revenue $ 14.65B $ 3.44B $ 3.37B Net Cash Flow $ 7.83B $ 3.12B $ 1.74B PE Ratio 18.30